Aryl and heteroaryl compounds and methods to modulate coagulation

This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus,...

Full description

Saved in:
Bibliographic Details
Main Authors Mjalli, Adnan M. M, Andrews, Robert C, Guo, Xiao-Chuan, Christen, Daniel Peter, Gohimmukkula, Devi Reddy, Huang, Guoxiang, Rothlein, Robert, Tyagi, Sameer, Yaramasu, Tripura, Behme, Christopher
Format Patent
LanguageEnglish
Published 17.10.2006
Online AccessGet full text

Cover

More Information
Summary:This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.